- XBiotech Inc XBIT shares tumbled 38.9 percent to $10.40 after the company disclosed that the EMA rendered negative trend vote related to MAA for its candidate antibody for the treatment of colorectal cancer.
- Adamis Pharmaceuticals Corp ADMP shares declined 16.5 percent to $3.67. Adamis Pharmaceuticals priced its 4.28 million offering at $3.50 per share.
- Aevi Genomic Medicine, Inc GNMX shares dropped 15.1 percent to $1.58. Aevi Genomic Medicine presents updated results from its SAGA trial of AEVI-001 at the 6th World Congress on ADHD on April 21, 2017.
- bebe stores, inc. BEBE declined 14.4 percent to $3.22 as the company disclosed that it has entered into consulting agreement to sell all merchandise and inventory, and also close all its stores.
- Apricus Biosciences Inc APRI dropped 13 percent to $1.21. Apricus Biosciences priced its offering of 5.03 million units at $1.40 per unit.
- Onconova Therapeutics Inc ONTX shares fell 11.7 percent to $2.19. Onconova Therapeutics priced its 2.47 million share offering at $2.10 per share.
- Clearwater Paper Corp CLW shares dipped 11.4 percent to $50.50 after the company reported Q1 results. Clearwater Paper reported Q1 adjusted earnings of $0.64 per share on revenue of $437.5 million.
- Mattel, Inc. MAT declined 10.4 percent to $22.59 as the company reported weaker-than-expected results for its first quarter on Thursday.
- Electronics For Imaging, Inc. EFII fell 9.5 percent to $46.04 after the company reported downbeat quarterly revenue.
- Fairmount Santrol Holdings Inc FMSA shares dropped 9 percent to $5.05. Barclays downgraded Fairmount Santrol from Overweight to Equal-Weight.
- Cleveland BioLabs, Inc. CBLI shares dropped 7.7 percent to $3.94 after falling 16.27 percent on Thursday.
- National Beverage Corp. FIZZ shares declined 5.8 percent to $85.00. Credit Suisse downgraded National Beverage from Outperform to Neutral.
- Manhattan Associates, Inc. MANH shares slipped 5.4 percent to $47.87. Manhattan Associates posted upbeat quarterly earnings, but sales missed estimates. The company also cut its FY17 sales outlook.
- Maxim Integrated Products Inc. MXIM declined 3.6 percent to $43.83. Maxim Integrated reported Q3 earnings of $0.56 per share on revenue of $581 million. Evercore ISI Group downgraded the stock from Outperform to In-Line.
- Immune Pharmaceuticals Inc IMNP fell 3.3 percent to $3.53 after surging 49.59 percent on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: NewsMovers & ShakersIntraday UpdateMarketsAnalyst RatingsApplication SoftwareConsumer DiscretionaryInformation TechnologyLeisure ProductsMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
